Summary & Overview
Minor Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview
DRG 345 encompasses minor small and large bowel procedures accompanied by a Complication or Comorbidity, covering limited resections, repairs, and ostomy-related operations. This matters for inpatient reimbursement because the Complication or Comorbidity designation increases expected resource use and shifts Centers for Medicare & Medicaid Services payment relative to non-Comorbidity cases.
DRG 345 Overview
DRG 345 covers hospital inpatient admissions for minor small and large bowel procedures when a Complication or Comorbidity is present. Typical cases include limited resections, repairs, or ostomy-related procedures without a Major Complication or Comorbidity but with a documented Complication or Comorbidity that impacts resource use. This Diagnosis-Related Group matters for Centers for Medicare & Medicaid Services payment because the presence of a Complication or Comorbidity elevates the expected resource consumption and reimbursement relative to cases without such comorbidity. Accurate clinical coding and documentation determine assignment to this Diagnosis-Related Group and therefore influence Medicare inpatient payment levels.
Clinical Trials
- Randomized studies of perioperative infection prevention strategies for minor small and large bowel procedures with CC: These trials compare interventions such as optimized antimicrobial prophylaxis timing, bowel prep regimens, or standardized surgical site infection care bundles in adult inpatients undergoing low-to-moderate complexity bowel resections or repairs who have at least one complicating condition (eg, diabetes, chronic steroid use). The objective is to reduce postoperative infectious complications and readmissions in a population at elevated risk due to comorbidities; results are directly relevant to surgeons and hospital quality teams and can inform payer metrics tied to length of stay and readmission penalties.
- Comparative effectiveness research on operative approaches and resource utilization: Pragmatic cohort or registry-based studies evaluate outcomes, complication rates, and hospital resource use (operative time, LOS, ICU utilization) between minimally invasive versus open approaches, or between different anastomotic techniques, in patients classified under this DRG with accompanying CCs like malnutrition or prior abdominal surgery. These studies address which procedural choices best balance clinical outcomes and costs for patients with complicating conditions, helping providers refine care pathways and payers assess value and reimbursement strategies.
- Post-discharge recovery and functional outcomes studies in medically complex bowel surgery patients: Prospective observational or interventional studies follow patients after discharge to measure wound healing, return to baseline bowel function, narcotic use, and rates of post-discharge complications or readmission, specifically focusing on those with CCs such as chronic kidney disease or congestive heart failure that affect recovery. Understanding longer-term outcomes and predictors of poor recovery informs discharge planning, transitional care interventions, and payer decisions about coverage for home health, rehabilitation, or close outpatient monitoring to prevent costly readmissions.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.